Concepts (116)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proton Pump Inhibitors | 4 | 2020 | 91 | 1.790 |
Why?
|
| Gastric Bypass | 2 | 2017 | 83 | 1.070 |
Why?
|
| Liver Cirrhosis | 5 | 2019 | 301 | 0.880 |
Why?
|
| Histamine | 1 | 2020 | 52 | 0.720 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2020 | 163 | 0.630 |
Why?
|
| Patient Admission | 1 | 2019 | 99 | 0.620 |
Why?
|
| Hepatitis, Autoimmune | 1 | 2017 | 22 | 0.570 |
Why?
|
| Liver Neoplasms | 2 | 2020 | 334 | 0.570 |
Why?
|
| Patient Readmission | 1 | 2019 | 267 | 0.540 |
Why?
|
| Jaundice | 1 | 2014 | 13 | 0.500 |
Why?
|
| Gastroesophageal Reflux | 1 | 2017 | 318 | 0.500 |
Why?
|
| Liver Failure, Acute | 1 | 2014 | 49 | 0.480 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2014 | 131 | 0.440 |
Why?
|
| Models, Statistical | 1 | 2014 | 448 | 0.380 |
Why?
|
| Algorithms | 1 | 2014 | 1196 | 0.320 |
Why?
|
| Ulcer | 2 | 2020 | 27 | 0.320 |
Why?
|
| Hepatitis C, Chronic | 2 | 2017 | 86 | 0.260 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2019 | 185 | 0.260 |
Why?
|
| United States Department of Veterans Affairs | 4 | 2019 | 307 | 0.240 |
Why?
|
| Humans | 19 | 2021 | 68618 | 0.230 |
Why?
|
| Treatment Outcome | 5 | 2021 | 7029 | 0.220 |
Why?
|
| Depression | 2 | 2021 | 943 | 0.210 |
Why?
|
| Pyloromyotomy | 1 | 2021 | 1 | 0.200 |
Why?
|
| Gastroparesis | 1 | 2021 | 7 | 0.200 |
Why?
|
| Hospitals, Veterans | 2 | 2019 | 147 | 0.190 |
Why?
|
| Hospital Mortality | 2 | 2020 | 384 | 0.190 |
Why?
|
| Gastrointestinal Diseases | 1 | 2021 | 107 | 0.190 |
Why?
|
| Intensive Care Units | 2 | 2020 | 344 | 0.190 |
Why?
|
| Liver Cirrhosis, Biliary | 1 | 2020 | 9 | 0.180 |
Why?
|
| Histamine H2 Antagonists | 1 | 2020 | 45 | 0.180 |
Why?
|
| Respiration, Artificial | 1 | 2020 | 190 | 0.170 |
Why?
|
| Acute-On-Chronic Liver Failure | 1 | 2018 | 2 | 0.160 |
Why?
|
| Data Warehousing | 1 | 2019 | 21 | 0.160 |
Why?
|
| Exocrine Pancreatic Insufficiency | 1 | 2018 | 6 | 0.160 |
Why?
|
| Pancreatic Elastase | 1 | 2018 | 33 | 0.150 |
Why?
|
| Interferon-gamma Release Tests | 1 | 2017 | 6 | 0.150 |
Why?
|
| Feces | 1 | 2018 | 88 | 0.150 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2018 | 51 | 0.150 |
Why?
|
| Diagnostic Errors | 1 | 2017 | 100 | 0.140 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2017 | 59 | 0.140 |
Why?
|
| Capsules | 1 | 2017 | 18 | 0.140 |
Why?
|
| Cohort Studies | 3 | 2018 | 2358 | 0.140 |
Why?
|
| Tuberculosis | 1 | 2017 | 77 | 0.140 |
Why?
|
| Prognosis | 2 | 2019 | 2093 | 0.140 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2017 | 103 | 0.140 |
Why?
|
| Female | 11 | 2021 | 38074 | 0.140 |
Why?
|
| Esophageal and Gastric Varices | 1 | 2016 | 47 | 0.130 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2017 | 618 | 0.130 |
Why?
|
| Psychiatric Rehabilitation | 1 | 2015 | 1 | 0.130 |
Why?
|
| United States | 5 | 2019 | 7367 | 0.130 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2016 | 189 | 0.130 |
Why?
|
| Male | 10 | 2021 | 37321 | 0.130 |
Why?
|
| Mortality | 1 | 2016 | 163 | 0.130 |
Why?
|
| Alcohol Abstinence | 1 | 2015 | 23 | 0.130 |
Why?
|
| Risk Assessment | 2 | 2019 | 2007 | 0.130 |
Why?
|
| Referral and Consultation | 1 | 2017 | 383 | 0.120 |
Why?
|
| Activities of Daily Living | 1 | 2016 | 319 | 0.120 |
Why?
|
| Middle Aged | 8 | 2019 | 21147 | 0.120 |
Why?
|
| Risk Factors | 3 | 2019 | 5731 | 0.120 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2017 | 931 | 0.110 |
Why?
|
| Liver Diseases | 1 | 2015 | 193 | 0.110 |
Why?
|
| Behavior Therapy | 1 | 2015 | 297 | 0.110 |
Why?
|
| Incidence | 1 | 2017 | 1603 | 0.110 |
Why?
|
| Aged | 5 | 2019 | 14862 | 0.100 |
Why?
|
| Mass Screening | 1 | 2017 | 843 | 0.100 |
Why?
|
| Time Factors | 1 | 2019 | 4655 | 0.090 |
Why?
|
| Retrospective Studies | 2 | 2019 | 7277 | 0.080 |
Why?
|
| Alcoholism | 1 | 2015 | 1109 | 0.070 |
Why?
|
| Proportional Hazards Models | 2 | 2016 | 792 | 0.060 |
Why?
|
| Survival Rate | 2 | 2017 | 1056 | 0.060 |
Why?
|
| Sensitivity and Specificity | 2 | 2018 | 1753 | 0.060 |
Why?
|
| Comorbidity | 2 | 2016 | 1426 | 0.050 |
Why?
|
| Hospitalization | 2 | 2018 | 978 | 0.050 |
Why?
|
| Pylorus | 1 | 2021 | 6 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2021 | 3705 | 0.050 |
Why?
|
| Age Factors | 2 | 2016 | 1864 | 0.050 |
Why?
|
| Cholagogues and Choleretics | 1 | 2020 | 2 | 0.050 |
Why?
|
| Electric Stimulation | 1 | 2021 | 218 | 0.050 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2020 | 4 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 4848 | 0.040 |
Why?
|
| Anxiety Disorders | 1 | 2021 | 426 | 0.040 |
Why?
|
| Anxiety | 1 | 2021 | 422 | 0.040 |
Why?
|
| Cognition | 1 | 2021 | 513 | 0.040 |
Why?
|
| Nadolol | 1 | 2016 | 1 | 0.040 |
Why?
|
| Hepacivirus | 1 | 2017 | 90 | 0.040 |
Why?
|
| Adult | 3 | 2021 | 21403 | 0.040 |
Why?
|
| Ascites | 1 | 2016 | 38 | 0.030 |
Why?
|
| Propranolol | 1 | 2016 | 103 | 0.030 |
Why?
|
| End Stage Liver Disease | 1 | 2016 | 60 | 0.030 |
Why?
|
| Primary Prevention | 1 | 2016 | 115 | 0.030 |
Why?
|
| Cause of Death | 1 | 2016 | 241 | 0.030 |
Why?
|
| Self Report | 1 | 2017 | 371 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2017 | 294 | 0.030 |
Why?
|
| Heart Rate | 1 | 2016 | 568 | 0.030 |
Why?
|
| Prevalence | 1 | 2018 | 1619 | 0.030 |
Why?
|
| Health Status | 1 | 2016 | 429 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2017 | 1553 | 0.030 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 207 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 1046 | 0.030 |
Why?
|
| Sex Factors | 1 | 2016 | 1266 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 1745 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2018 | 2455 | 0.020 |
Why?
|
| Infant | 1 | 2018 | 2891 | 0.020 |
Why?
|
| Veterans | 1 | 2018 | 904 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 1851 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2018 | 3187 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 694 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2016 | 696 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 2016 | 805 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 2800 | 0.020 |
Why?
|
| Smoking | 1 | 2016 | 1452 | 0.020 |
Why?
|
| Heart Failure | 1 | 2016 | 1180 | 0.020 |
Why?
|
| Hypertension | 1 | 2016 | 1535 | 0.020 |
Why?
|
| Child | 1 | 2018 | 6405 | 0.020 |
Why?
|
| Young Adult | 1 | 2018 | 5717 | 0.020 |
Why?
|
| Adolescent | 1 | 2018 | 8912 | 0.020 |
Why?
|